Consistently, GSEA analysis indicated that FEN1 might participate in various pathways, such as cell cycle, DNA replication, cell cycle checkpoints, TP53-modulated genes transcription, liver cancer proliferation, EMT promotion, senescence TP53 targets, and TP53/TP73 signaling (Figure 5C). This evidence concerns the gene TP73 and liver cancer.